Veterinary Orthopedic Surgical Tta Instrument Set Without Implants

Name: Veterinary Orthopedic Surgical Tta Instrument Set Without Implants
Brand: Xc Technology Co., Ltd.
SKU: 2263111065

Jiangsu, ChinaXc Technology Co., Ltd.

US$500.00

1-4 Pieces

US$490.00

5-19 Pieces

US$480.00

20+ Pieces

Sample price:US$500.00/piece.Request sample

Product profile

Type

Tta Instrument Set-No Implant

Syringe

Blood Sampling Needle

Model NO.

TTA Instrument Set-No implant

Breathing Pattern

Animal Anesthesia Machine Control Method

Instrument Classification

Class III

Samples

Avaliable

Warranty

1 Year

Application

Vet Surgery

Product Name

Tta Instrument Set

Product Type

General Surgery Veterinary Instruments

Brand Name

Xc Medico

Feature

Easy Operation

Usage

Animal Surgery Animal Veterinary Instruments

Keyword

Veterinary Instruments

Function

Surgery Medical

Advantage

Long Time Used

Suitable for

Dogs Cats Small Animals

Quality

100% High

OEM&ODM

Avaliable

Transport Package

Box

Trademark

XC MEDICO

Origin

China

Production Capacity

1000set/Month

Company profile

In-stock CapacityFast DeliveryRaw-Materials TraceabilityQuality Assurance

Xc Technology Co., Ltd.

Jiangsu, China

CertifiedBusiness Type: Trading Company CertifiedCustomization Options: Minor Customization CertifiedExport Year: 6 Years CertifiedNearest Port: Shanghai PortAverage Response Time: ≤6.84h CertifiedTerms of Payment: LC, T/T, D/P, etc.

AI-Powered supplier vetting

SummaryXC Medico is identified as a trading company serving the health and medicine sector, with orthopedic instruments as a key product area. The supplier reports 18 years of orthopedic experience, certified production lines and warehouses, raw-material traceability, and 100% finished-product inspection, although inspection is performed by packing staff and only one quality inspector is reported. Service infrastructure is limited: no overseas warehouses, showrooms, agents or branches, and no offline trade-show participation. Formal service procedures, corrective/preventive-action records, and complaint-handling procedures are not provided. Innovation evidence is weak, with no new products in the past year, no ODM, OEM for popular brands, or SDK. Minor customization is available. Certification is mentioned, but specific certificates are not identified. Customer cases are not documented.

After-Sales capabilityThe supplier claims technical support covering preoperative planning, intraoperative assistance, and postoperative traceability and complication management. Against this, it reports no written service procedures or records, no formal corrective/preventive-action mechanism, no documented complaint-handling process, and no overseas warehouses, showrooms, agents or branches; therefore, structured and geographically accessible after-sales capability is not demonstrated.

R&D capabilityThe supplier describes experienced engineers and product development and innovation, but reports no new products during the past year, no ODM service, no OEM for popular brands, and no available SDK. The explicit recent innovation and development offerings therefore indicate a deficiency.

Production capacityThe supplier states that it operates certified production lines and warehouses, has a 668.0 m² manufacturing plant, provides raw-material traceability, and conducts 100% finished-product inspection. However, finished products are checked by packing staff and only one quality inspector is reported; production capability is supported by facility and control claims, but its scale and robustness are only partially evidenced.

Customization capabilityThe supplier explicitly offers minor customization. This confirms some customization capability, but the evidence does not show advanced engineering customization, extensive configuration options, or full OEM/ODM support.